Signal loss due to oligomerization in ELISA analysis of amyloid-beta can be recovered by a novel sample pre-treatment method

MethodsX

Volumn 2, Issue , 2015, Pages 112-123

  Janssen, Leen ^a   Sobott, Frank ^a   De Deyn, Peter P ^a,b,c,d   Van Dam, Debby ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Memory Clinic   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Alzheimer's disease; Amyloid beta; ELISA; Oligomers; Sample pre treatment; Steric hindrance

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; EPITOPE; FORMIC ACID; HEXAFLUORO 2 PROPANOL; MONOMER; OLIGOMER; PROTEIN AGGREGATE; TRIFLUOROACETIC ACID;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; STEREOSPECIFICITY; WESTERN BLOTTING;

MUS;

EID: 84924698797     PISSN: None     EISSN: 22150161     Source Type: Journal    
DOI: 10.1016/j.mex.2015.02.011     Document Type: Article

References (40)

1. S.C. Jao, K. Ma, J. Talafous, R. Orlando, and M.G. Zagorski Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid beta-peptide Amyloid 4 1997 240 252
2. W.B. Stine Jr., K.N. Dahlgren, G.A. Krafft, and M.J. LaDu In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J. Biol. Chem. 278 2003 11612 11622
3. D.J. Selkoe, C.R. Abraham, M.B. Podlisny, and L.K. Duffy Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease J. Neurochem. 46 1986 1820 1834
4. D.A. Ryan, W.C. Narrow, H.J. Federoff, and W.J. Bowers An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies J. Neurosci. Methods 190 2010 171 179
5. M.A. Sherman, and S.E. Lesne Detecting abeta∗56 oligomers in brain tissues Methods Mol. Biol. 670 2011 45 561
6. A.D. Watt, K.A. Perez, A. Rembach, N.A. Sherrat, L.W. Hung, T. Johanssen, C.A. McLean, W.M. Kok, C.A. Hutton, M. Fodero-Tavoletti, C.L. Masters, V.L. Villemagne, and K.J. Barnham Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples Acta Neuropathol. 125 4 2013 549 564
7. D.M. Walsh, and D.J. Selkoe A beta oligomers - a decade of discovery J. Neurochem. 101 2007 1172 1184
8. A.L. Lublin, and S. Gandy Amyloid-beta oligomers: possible roles as key neurotoxins in Alzheimer's Disease Mt. Sinai J. Med. 77 2010 43 49
9. A. Goate, and J. Hardy Twenty years of Alzheimer's disease-causing mutations J. Neurochem. 120 Suppl 1 2012 3 8
10. M.E. Larson, and S.E. Lesne Soluble Abeta oligomer production and toxicity J. Neurochem. 120 Suppl 1 2012 125 139
11. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
12. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
13. D.W. Dickson, H.A. Crystal, C. Bevona, W. Honer, I. Vincent, and P. Davies Correlations of synaptic and pathological markers with cognition of the elderly Neurobiol. Aging 16 1995 285 298 discussion 298-304
14. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
15. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
16. J. Wang, D.W. Dickson, J.Q. Trojanowski, and V.M. Lee The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging Exp. Neurol. 158 1999 328 337
17. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
18. C.R. Jack Jr., D.W. Dickson, J.E. Parisi, Y.C. Xu, R.H. Cha, P.C. O'Brien, S.D. Edland, G.E. Smith, B.F. Boeve, E.G. Tangalos, E. Kokmen, and R.C. Petersen M.R.I. antemortem findings correlate with hippocampal neuropathology in typical aging and dementia Neurology 58 2002 750 757
19. D.H. Silverman, S.S. Gambhir, H.W. Huang, J. Schwimmer, S. Kim, G.W. Small, J. Chodosh, J. Czernin, and M.E. Phelps Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits J. Nucl. Med. 43 2002 253 266
20. F. Hulstaert, K. Blennow, A. Ivanoiu, H.C. Schoonderwaldt, M. Riemenschneider, P.P. De Deyn, C. Bancher, P. Cras, J. Wiltfang, P.D. Mehta, K. Iqbal, H. Pottel, E. Vanmechelen, and H. Vanderstichele Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1999 1555 1562
21. O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow, and L. Minthon Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol. 5 2006 228 234
22. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D.P. Holt, M. Bergstrom, I. Savitcheva, G.F. Huang, S. Estrada, B. Ausen, M.L. Debnath, J. Barletta, J.C. Price, J. Sandell, B.J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C.A. Mathis, and B. Langstrom Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55 2004 306 319
23. K. Shoghi-Jadid, G.W. Small, E.D. Agdeppa, V. Kepe, L.M. Ercoli, P. Siddarth, S. Read, N. Satyamurthy, A. Petric, S.C. Huang, and J.R. Barrio Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am. J. Geriatr. Psychiatry 10 2002 24 35
24. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O'Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P.J. Visser, and P. Scheltens Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol. 6 2007 734 746
25. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., C.H. Kawas, W.E. Klunk, W.J. Koroshetz, J.J. Manly, R. Mayeux, R.C. Mohs, J.C. Morris, M.N. Rossor, P. Scheltens, M.C. Carrillo, B. Thies, S. Weintraub, and C.H. Phelps The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement. 7 2011 263 269
26. C. Stenh, H. Englund, A. Lord, A.S. Johansson, C.G. Almeida, P. Gellerfors, P. Greengard, G.K. Gouras, L. Lannfelt, and L.N. Nilsson Amyloid-beta oligomers are inefficiently measured by enzyme-linked immunosorbent assay Ann. Neurol. 58 2005 147 150
27. H. Englund, M. Degerman Gunnarsson, R.M. Brundin, M. Hedlund, L. Kilander, L. Lannfelt, and F.E. Pettersson Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid Neurodegener. Dis. 6 2009 139 147
28. A.E. Roher, J. Baudry, M.O. Chaney, Y.M. Kuo, W.B. Stine, and M.R. Emmerling Oligomerizaiton and fibril asssembly of the amyloid-beta protein Biochim. Biophys. Acta 1502 2000 31 43
29. H. Englund, D. Sehlin, A.S. Johansson, L.N. Nilsson, P. Gellerfors, S. Paulie, L. Lannfelt, and F.E. Pettersson Sensitive ELISA detection of amyloid-beta protofibrils in biological samples J. Neurochem. 103 2007 334 345
30. Z. van Helmond, K. Heesom, and S. Love Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates J. Neurosci. Methods 176 2009 206 212
31. A.Z. Herskovits, J.J. Locascio, E.R. Peskind, G. Li, and B.T. Hyman A Luminex assay detects amyloid beta oligomers in Alzheimer's disease cerebrospinal fluid PLoS One 8 2013 e67898
32. T. Yang, S. Hong, T. O'Malley, R.A. Sperling, D.M. Walsh, and D.J. Selkoe New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF Alzheimers Dement. 9 2013 99 112
33. A. Lord, A. Gumucio, H. Englund, D. Sehlin, V.S. Sundquist, L. Soderberg, C. Moller, P. Gellerfors, L. Lannfelt, F.E. Pettersson, and L.N. Nilsson An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease Neurobiol. Dis. 36 2009 425 434
34. H. Fukumoto, T. Tokuda, T. Kasai, N. Ishigami, H. Hidaka, M. Kondo, D. Allsop, and M. Nakagawa High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients FASEB J. 24 2010 2716 2726
35. W. Xia, T. Yang, G. Shankar, I.M. Smith, Y. Shen, D.M. Walsh, and D.J. Selkoe A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease Arch. Neurol. 66 2009 190 199
36. M. Holtta, O. Hansson, U. Andreasson, J. Hertze, L. Minthon, K. Nagga, N. Andreasen, H. Zetterberg, and K. Blennow Evaluating amyloid-beta oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease PLoS One 8 2013 e66381
37. M.J. Savage, J. Kalinina, A. Wolfe, K. Tugusheva, R. Korn, T. Cash-Mason, J.W. Maxwell, N.G. Hatcher, S.J. Haugabook, G. Wu, B.J. Howell, J.J. Renger, P.J. Shughrue, and A. McCampbell A sensitive abeta oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid J. Neurosci. 34 2014 2884 2897
38. D.G. Georganopoulou, L. Chang, J.M. Nam, C.S. Thaxton, E.J. Mufson, W.L. Klein, and C.A. Mirkin Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 2273 2276
39. L. Wang-Dietrich, S.A. Funke, K. Kühbach, K. Wang, A. Besmehn, S. Willbold, Y. Cinar, O. Bannach, E. Birkmann, and D. Willbold The amyloid-beta oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease J. Alzheimers Dis. 34 2013 985 994
40. A.N. Santos, S. Torkler, D. Nowak, C. Schlittig, M. Goerdes, T. Lauber, L. Trischmann, M. Schaupp, M. Penz, F.W. Tiller, and G. Bohm Detection of amyloid-beta oligomers in human cerebrospinal fluid by flow cytometry and fluorescence resonance energy transfer J. Alzheimers Dis. 11 2007 117 125